Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Moxifloxacin for MDR-TB Culture Conversion
NCT01055145Phase 3Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2010
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in multidrug-resistant tuberculosis (MDR-TB), sponsored by Seoul National University Hospital. Started Mar 2010; status: terminated.
02
Drugs
moxifloxacin
03
Conditions
multidrug-resistant tuberculosis (MDR-TB)
Beyond the preview
Go deeper on NCT01055145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055145.